NCT00675909View on ClinicalTrials.gov

Improving Sedation of Children Undergoing Procedures in the Emergency Department

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Anxiety
Interventions
DRUG

Aerosolized Intranasal midazolam

"Midazolam will be administered via aerosolization (using atomizer) with half of dose in each nostril. Total dose is 0.3mg/kg."

DRUG

Aerosolized Buccal Midazolam

"0.3mg/kg total dose administered with aerosolization device (atomizer) sprayed onto buccal mucosa inside the cheek on both sides of mouth."

DRUG

Oral midazolam

oral midazolam 0.5mg/kg

All Listed Sponsors
lead

Seattle Children's Hospital

OTHER

NCT00675909 - Improving Sedation of Children Undergoing Procedures in the Emergency Department | Biotech Hunter | Biotech Hunter